HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (33) Citing Articles via Google Scholar Google Scholar Articles by Gamba, G. Search for Related Content PubMed PubMed Citation Articles by Gamba, G.

INVITED REVIEW

Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension

Molecular Physiology Unit, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, and Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico

A recently discovered family of protein kinases is responsible for an autosomal-dominant disease known as Gordon's syndrome or pseudohypoaldosteronism type II (PHA-II) that features hyperkalemia and hyperchloremic metabolic acidosis, accompanied by hypertension and hypercalciuria. Four genes have been described in this kinase family, which has been named WNK, due to the absence of a key lysine in kinase subdomain II (with no K kinases). Two of these genes, WNK1 and WNK4 located in human chromosomes 12 and 17, respectively, are responsible for PHA-II. Immunohystochemical analysis revealed that WNK1 and WNK4 are predominantly expressed in the distal convoluted tubule and collecting duct. The physiological studies have shown that WNK4 downregulates the activity of ion transport pathways expressed in these nephron segments, such as the apical thiazide-sensitive Na⁺-Cl^– cotransporter and apical secretory K⁺ channel ROMK, as well as upregulates paracellular chloride transport and phosphorylation of tight junction proteins such as claudins. In addition, WNK4 downregulates other Cl^– influx pathways such as the basolateral Na⁺-K⁺-2Cl^– cotransporter and Cl^–/HCO₃^– exchanger. WNK4 mutations behave as a loss of function for the Na⁺-Cl^– cotransporter and a gain of function when it comes to ROMK and claudins. These dual effects of WNK4 mutations fit with proposed mechanisms for developing electrolyte abnormalities and hypertension in PHA-II and point to WNK4 as a multifunctional regulator of diverse ion transporters.

distal tubule; sodium chloride; diuretics; claudins; paracellular

This article has been cited by other articles:

				J. A. McCormick, C.-L. Yang, and D. H. Ellison WNK Kinases and Renal Sodium Transport in Health and Disease: An Integrated View Hypertension, March 1, 2008; 51(3): 588 - 596. [Full Text] [PDF]

				J.-B. Peng and D. G. Warnock WNK4-mediated regulation of renal ion transport proteins Am J Physiol Renal Physiol, October 1, 2007; 293(4): F961 - F973. [Abstract] [Full Text] [PDF]

				K. P. Choe and K. Strange Evolutionarily conserved WNK and Ste20 kinases are essential for acute volume recovery and survival after hypertonic shrinkage in Caenorhabditis elegans Am J Physiol Cell Physiol, September 1, 2007; 293(3): C915 - C927. [Abstract] [Full Text] [PDF]

				P. A. Sonalker and E. K. Jackson Norepinephrine, via {beta}-Adrenoceptors, Regulates Bumetanide-Sensitive Cotransporter Type 1 Expression in Thick Ascending Limb Cells Hypertension, June 1, 2007; 49(6): 1351 - 1357. [Abstract] [Full Text] [PDF]

				T. Garzon-Muvdi, D. Pacheco-Alvarez, K. B. E. Gagnon, N. Vazquez, J. Ponce-Coria, E. Moreno, E. Delpire, and G. Gamba WNK4 kinase is a negative regulator of K+-Cl- cotransporters Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1197 - F1207. [Abstract] [Full Text] [PDF]

				K. T. Kahle, J. Rinehart, A. Ring, I. Gimenez, G. Gamba, S. C. Hebert, and R. P. Lifton WNK Protein Kinases Modulate Cellular Cl- Flux by Altering the Phosphorylation State of the Na-K-Cl and K-Cl Cotransporters. Physiology, October 1, 2006; 21: 326 - 335. [Abstract] [Full Text] [PDF]

				G. Gamba TRPV4: a new target for the hypertension-related kinases WNK1 and WNK4 Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1303 - F1304. [Full Text] [PDF]

				L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF]

				A. R. Subramanya, C.-L. Yang, X. Zhu, and D. H. Ellison Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform Am J Physiol Renal Physiol, March 1, 2006; 290(3): F619 - F624. [Abstract] [Full Text] [PDF]

				K. Strange, J. Denton, and K. Nehrke Ste20-Type Kinases: Evolutionarily Conserved Regulators of Ion Transport and Cell Volume Physiology, February 1, 2006; 21(1): 61 - 68. [Abstract] [Full Text] [PDF]

				D. B. N. Lee, E. Huang, and H. J. Ward Tight junction biology and kidney dysfunction Am J Physiol Renal Physiol, January 1, 2006; 290(1): F20 - F34. [Abstract] [Full Text] [PDF]

				G. Bianchi Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1536 - R1549. [Abstract] [Full Text] [PDF]

				A. P. Golbang, M. Murthy, A. Hamad, C.-H. Liu, G. Cope, W. Van't Hoff, A. Cuthbert, and K. M. O'Shaughnessy A New Kindred With Pseudohypoaldosteronism Type II and a Novel Mutation (564D>H) in the Acidic Motif of the WNK4 Gene Hypertension, August 1, 2005; 46(2): 295 - 300. [Abstract] [Full Text] [PDF]